Datapoint: Capital Blue Cross Becomes First Payer to Partner With Mark Cuban Cost Plus Drug Company

Pennsylvania Blues insurer Capital Blue Cross last week said it is partnering with Mark Cuban Cost Plus Drug Company (MCCPDC) to bring low-cost generic drugs to its members. MCCPDC charges consumers 15% more than its acquisition cost from the manufacturer, offering average savings of 80% on common generic drugs compared to retail prices. Capital Blue Cross is MCCPDC’s first payer partner, and the insurer said members can already begin accessing their prescriptions through MCCPDC online. Members will be able to use their insurance cards at MCCPDC locations next year. Capital Blue Cross currently serves 720,408 members in Pennsylvania, with 31.1% enrolled in commercial risk-based plans, and 62.6% in self-funded arrangements.

Source: AIS’s Directory of Health Plans

0 Comments
AIS Health Staff

AIS Health Staff

Related Posts

businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
February 29

Datapoint: FDA Approves Latest Humira Biosimilar

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
February 28

Datapoint: Xolair Scores FDA Nod for Food Allergies

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
February 27

Datapoint: Aetna Sees Strong MA Growth

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today